Wedelolactone Mitigates Alcoholic Steatohepatitis via Modulating the TLR4/MyD88/NF-κB Pathway
Background. Wedelolactone (WEL) has demonstrated anti-inflammatory properties. However, the therapeutic effect and underlying mechanisms of WEL against alcoholic steatohepatitis (ASH) remain unclear. This study aimed to investigate these aspects using animal and cell models. Methods and Results. The...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2024/9185668 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|